Insider Files Form 144 to Sell 14,433 SRE Shares Via Oppenheimer

Rhea-AI Filing Summary

Form 144 notice for Sempra (SRE) indicates a proposed sale of 14,433 shares of Sempra common stock through Oppenheimer & Co., with an aggregate market value of $1,278,619.47. The filing lists approximately 652,472,426 shares outstanding and an approximate sale date of 09/29/2025. The securities were acquired through vesting of restricted stock units: 144 shares on 01/15/2025 (reinvested dividends), 11,711 shares on 01/28/2025, and 2,578 shares on 02/19/2025, all as compensation under Sempra's long-term incentive plan. The filer also reported a sale by Kevin C. Sagara of 28,864 shares on 09/15/2025 for gross proceeds of $2,430,591.00. The notice includes the standard insider representation about material nonpublic information.

Positive

• Full disclosure of acquisition dates and amounts for the shares being sold, including vesting details
• Broker and approximate sale date provided, enabling market transparency
• Prior sale by Kevin C. Sagara disclosed with exact proceeds, improving investor visibility

Negative

• Insider sale activity indicates insider liquidity but may be perceived negatively by some investors
• No context on purpose of sale (e.g., diversification, tax), which leaves investor interpretation open

Insights

Securities Analyst

TL;DR: Insider plans to sell 14,433 shares (about $1.28M) that were recently acquired via RSU vesting; prior sale of 28,864 shares generated $2.43M.

The filing documents a routine Rule 144 notice for securities received as compensation through restricted stock unit vesting earlier in 2025. The use of a broker (Oppenheimer & Co.) and the separate recent sale by Kevin C. Sagara are consistent with standard insider liquidity events rather than corporate actions. For investors, this is transparent disclosure of insider selling activity; it does not itself provide financial performance information about Sempra.

Corporate Governance Expert

TL;DR: This is a compliant Form 144 reporting insider sales tied to equity compensation vesting and a recent related sale.

The filing contains the required elements: acquisition dates, nature of acquisition (vesting and reinvested dividends), amounts, broker details, and previous sales within three months. The signer affirms lack of undisclosed material information. From a governance perspective, the filing demonstrates adherence to disclosure rules for insider transactions; no governance violations or unusual arrangements are apparent from the document alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Oppenheimer & Co., Inc. 10880 Wilshire Boulevard Los Angeles CA 90024	14433	1278619.47	652472426	09/29/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/15/2025	Reinvested dividends from certain vested restricted stock units	Sempra			144	01/15/2025	Vesting of equity award received as compensation
Common Stock	01/28/2025	Vesting of grant of restricted stock units under Sempra's Long-Term Incentive Plan	Sempra			11711	01/28/2025	Vesting of equity award received as compensation
Common Stock	02/19/2025	Vesting of grant of restricted stock units under Sempra's Long-Term Incentive Plan	Sempra			2578	02/19/2025	Vesting of equity award received as compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kevin C. Sagara 488 8th Avenue San Diego CA 92101	Common Stock	09/15/2025	28864	2430591.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for SRE report?

The Form 144 reports a proposed sale of 14,433 Sempra (SRE) common shares with an aggregate market value of $1,278,619.47, to be sold via Oppenheimer & Co. on or about 09/29/2025.

How were the securities to be sold acquired?

The securities were acquired through vesting of restricted stock units and reinvested dividends on 01/15/2025, 01/28/2025, and 02/19/2025 as compensation from Sempra.

Did the filer sell other Sempra shares recently?

Yes. The filing discloses a sale by Kevin C. Sagara of 28,864 shares on 09/15/2025 for gross proceeds of $2,430,591.00.

Which broker is handling the proposed sale?

The broker listed is Oppenheimer & Co., Inc. with an address at 10880 Wilshire Boulevard, Los Angeles, CA.

Does the Form 144 indicate any undisclosed material information?

By signing the notice, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.